Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial [0.03%]
左乙酰半胱氨酸治疗共济基管扩张症的疗效和安全性：一项随机、双盲、安慰剂对照交叉试验
Kyriakos Martakis,Tatiana Bremova-Ertl,Clare Bolton et al.
Kyriakos Martakis et al.
Background: Ataxia-telangiectasia is a rare, autosomal recessive neurodegenerative disorder. Levacetylleucine (N-acetyl-L-leucine) has been shown to be efficacious for the treatment of neurological manifestations and to h...
Clinical Trial
The Lancet. Neurology. 2026 Jul;25(7):633-644. DOI:10.1016/S1474-4422(26)00158-4 2026
Robert Stirrups
Robert Stirrups
Kazutoshi Takahashi,Shalini Agarwal,Arpan R Mehta
Kazutoshi Takahashi
Jules Morgan
Jules Morgan
Kurt-Wolfram Suehs,Lea Grote-Levi,Mira Schwarz et al.
Kurt-Wolfram Suehs et al.
Optic nerve involvement in multiple sclerosis diagnosis - Authors' reply [0.03%]
optic nerve involvement in multiple sclerosis诊断中的optic nerve involvement - 作者回复
Shiv Saidha,Ari J Green,Laura Balcer et al.
Shiv Saidha et al.
Wenjing Luo,Zhenshen Wei,Xinhui Huang et al.
Wenjing Luo et al.
The epidemiology of unruptured intracranial aneurysm in Finland - Authors' reply [0.03%]
芬兰未破裂颅内动脉瘤的流行病学分布——作者回应
Nima Etminan,Mervyn D I Vergouwen,Gabriel J E Rinkel
Nima Etminan
Aleksanteri Asikainen,Ilari Rautalin,Jaakko Kaprio et al.
Aleksanteri Asikainen et al.